| Home > Authorities > Institutes > Record #144953 |
TU03
DKTK TU AG Krebs-Immuntherapie| ID | I:(DE-He78)TU03-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19.
Clinical therapeutics 48(3), 232-239 (2026) [10.1016/j.clinthera.2026.01.004]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Carfilzomib preserves dendritic cell phenotype and function compared with bortezomib.
Frontiers in immunology 17, 1936021 (2026) [10.3389/fimmu.2026.1936021]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Loss of BECN1 does not compromise autophagosome formation but alters cargo selection and HLA-restricted antigen presentation of B cells.
Autophagy nn, nn (2026) [10.1080/15548627.2026.2719432]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Identification of novel HLA class I-restricted hepatitis B virus peptides and their modulation by peptide editor TAPBPR.
Frontiers in immunology 17, 1892820 (2026) [10.3389/fimmu.2026.1892820]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
The challenge of patient recruitment into early phase clinical trials: Is time-effective academic translational research feasible? Lessons from a phase I/II trial in patients with B-cell deficiencies.
Frontiers in medicine 13, 1844041 (2026) [10.3389/fmed.2026.1844041]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)
ImmunoTargets & therapy 15, 533342 (2026) [10.2147/ITT.S533342]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.
Cancer research 86(2), 367 - 386 (2026) [10.1158/0008-5472.CAN-25-0349]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study.
The lancet / Haematology 13(2), 26 (2026) [10.1016/S2352-3026(25)00323-0]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.
Cell 189(2), 569-584.e14 (2026) [10.1016/j.cell.2025.12.046]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.
Cancers 13(4), 596 (2021) [10.3390/cancers13040596]
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |